STAA

Staar Surgical

--(--)

Market Open: --

--(--)

Post-Market: --

Signals Analysis

Buy signal 1

Sell signal 1

Revenue Beats Expectation

EPS Below Expectations

Key Stats

--DAY`S RANGE--

--52 WK RANGE--

Open

Prev.Close

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

Low

52 Week High

52 Week Low

About STAA

Staar Surgical Company

A developer of implantable lenses for the eye and companion delivery systems

Industry

Healthcare Equipment and Supplies

Established Date

Invalid Date

Listing Date

10/26/1990

Exchange

NASDAQ Stock Exchange

Full-time Employees

1157

Fiscal Year Ends

12-31

Website

www.staar.com

Security Type

Common stock

Office address

25510 Commercentre Drive, Lake Forest, California 92630

Business

Introduction

Staar Surgical Company designs, develops, manufactures and sells implantable lenses. The company is the world's leading manufacturer of lenses used in corrective or "refractive" surgery, and its lenses are also used to treat cataract surgery. All of the company's lenses are foldable, allowing surgeons to insert them through a small incision during minimally invasive surgery. Refractive surgery corrects visual impairment, the traditional treatment of visual impairment such as glasses or contact lenses. The company refers to the lenses used in refractive surgery as "implantable intraocular contact lenses" or "intraocular lens implantation. ". The field of refractive surgery includes lens-based procedures using products such as ICL and laser-based procedures such as LASIK surgery. Successful refractive surgery can correct common vision disorders such as nearsightedness, farsightedness and astigmatism. STAAR Surgical was originally incorporated in California in 1982 and re-merged in Delaware in 1986.

Company Financials

EPS

STAA has released its 2024 Q4 earnings. EPS was reported at -0.69, versus the expected 0.00, missing expectations. The chart below visualizes how STAA has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

STAA has released its 2024 Q4 earnings report, with revenue of 48.95M, reflecting a YoY change of -35.82%, and net profit of -34.23M, showing a YoY change of -541.31%. The Sankey diagram below clearly presents STAA’s revenue sources and cost distribution.